High-grade, metastatic disease, and adjuvant radiotherapy are independent prognostic factors for progression-free survival in patients with solitary fibrous tumors
Our data shows that WHO grade 3, metastatic disease, and adjuvant radiotherapy are independent PFS factors in SFTs.
Authors
- Sandro M. Krieg (ORCID: https://orcid.org/0000-0003-4050-1531)
- Ramin Rahmanzade
- Andreas Unterberg (ORCID: https://orcid.org/0000-0003-3742-3288)
- Christel C. Herold‐Mende (ORCID: https://orcid.org/0000-0002-1915-745X)
- Jan Paul Alker
- Thomas Held (ORCID: https://orcid.org/0000-0002-3913-4693)
- Gerhard Jungwirth (ORCID: https://orcid.org/0000-0001-7571-8947)
- Felix Sahm (ORCID: https://orcid.org/0000-0001-5441-1962)
Institutions
- Heidelberg University (DE)
- Heidelberg University (US)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf077
- Citations
- 1
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Universität Heidelberg
- Else Kröner-Fresenius-Stiftung